Global CRISPR Technology Market - Focus on Product, Applications, Geographical Analysis, Industry Insights And Competitive Landscape - Analysis And Forecast (2018-2027)
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.
The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.
The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product’, ‘application’, and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.
The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.
The answers to the following key questions can be derived from this report:
The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.
The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.
The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product’, ‘application’, and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.
The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.
The answers to the following key questions can be derived from this report:
- How did the CRISPR technology market evolve, and what is its scope in the future?
- What are the major market drivers, challenges and opportunities in the global CRISPR technology market?
- What are the key developmental strategies that are being implemented by the key players to sustain in this market?
- How are the influencing factors will affect the industry attractiveness?
- How the CRISPR technology is being utilized for the development of therapeutics?
- How the investments by public & private companies, and government organizations will affect the global CRISPR technology market?
- What was the market size of the leading segments and sub-segments of the global CRISPR technology market in 2017?
- How will the industry evolve during the forecast period 2018- 2027?
- What will be the growth rate of the CRISPR technology during the forecast period?
- How will each segment of the global CRISPR technology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
- Which product segment, and application segment is expected to register the highest CAGR for the CRISPR technology market?
- What are the major benefits of the implementation of CRISPR technology in different field of applications including biological research, agricultural biotech, industrial biotech, and therapeutics & drug discovery?
- What is the market size of CRISPR technology in different countries of the world?
- Which geographical region will contribute to the highest sales of CRISPR technology?
- Who are the key players in the CRISPR technology market and what are their contributions?
EXECUTIVE SUMMARY
1 MARKET OVERVIEW
1.1 Introduction
1.2 CRISPR Technology Approach
1.3 Evolution of CRISPR Technology
1.4 CRISPR Technology: Areas of Interest
1.5 CRISPR Technology: Future Potential
1.6 Global Market
1.7 Assumptions and Limitations
2 MARKET DYNAMICS
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.4 Market Restraints
2.5 Market Opportunities
3 COMPETITIVE LANDSCAPE
3.1 Introduction
3.2 Key Developments and Strategies
3.3 Product Launches and Enhancements
3.4 Joint Ventures, Partnerships and Collaborations
3.5 Mergers and Acquisitions
3.6 Business Expansions, Awards, Recognitions, Certifications and Others
3.7 Industry Attractiveness
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Threat of New Entrants
3.7.4 Threat of Substitute Products
3.7.5 Intensity of Competitive Rivalry
3.8 Pipeline Analysis
4 INDUSTRY INSIGHTS
4.1 Introduction
4.2 Patent Analysis
4.3 Funding Scenario
4.3.1 Funding Scenario: Public Companies
4.3.2 Funding Scenario: Private Companies
4.3.3 Funding Scenario: Investments by Government Organizations
4.4 Legal Requirements and Regulations
4.5 List of Regulatory Bodies
5 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT
5.1 Overview
5.2 Designing Tools
5.3 Library
5.4 Control Kits
5.5 Plasmids
5.6 Vectors
5.7 Proteins
5.7.1 Cas9
5.7.2 Cpf1
5.7.3 Others
5.8 Grna
5.9 Others
6 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION
6.1 Overview
6.2 Biological Research
6.3 Agricultural Biotech
6.4 Industrial Biotech
6.5 Therapeutics and Drug Discovery
7 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION
7.1 Overview
7.2 Global Insights
7.3 North America
7.3.1 North America Market Dynamics
7.3.2 North America Market, by Country
7.3.2.1 The U.S.
7.3.2.2 Canada
7.4 Europe
7.4.1 Europe Market Dynamics
7.4.2 Europe Market, by Country
7.4.2.1 The U.K.
7.4.2.2 Germany
7.4.2.3 France
7.4.2.4 Spain
7.4.2.5 Italy
7.4.2.6 Switzerland
7.4.2.7 Rest of the Europe
7.5 Asia Pacific
7.5.1 Asia Pacific Market Dynamics
7.5.2 Asia Pacific, by Country
7.5.2.1 Japan
7.5.2.2 China
7.5.2.3 South Korea
7.5.2.4 Singapore
7.5.2.5 India
7.5.2.6 Rest of Asia Pacific
7.6 Rest of the World
8 COMPANY PROFILES
8.1 Agilent Technologies, Inc.
8.1.1 Overview
8.1.2 Overall Product Portfolio
8.1.3 Product Offerings for Global CRISPR Technology Market
8.1.4 Financials
8.1.4.1 Financial Summary
8.1.5 Global Presence
8.1.6 Recent Developments
8.1.7 SWOT Analysis
8.2 Applied StemCell, Inc.
8.2.1 Overview
8.2.2 Corporate Summary
8.2.3 Product Offerings for Global CRISPR Technology Market
8.2.4 Recent Developments
8.2.5 SWOT Analysis
8.3 Cellecta, Inc.
8.3.1 Overview
8.3.2 Corporate Summary
8.3.3 Product Offerings for Global CRISPR Technology Market
8.3.4 SWOT Analysis
8.4 Dharmacon, Inc.
8.4.1 Overview
8.4.2 Overall Product Portfolio
8.4.3 Product Offerings for Global CRISPR Technology Market
8.4.4 Financials
8.4.4.1 Financial Summary
8.4.5 Global Presence
8.4.6 Recent Developments
8.4.7 SWOT Analysis
8.5 DiaCarta, Inc.
8.5.1 Overview
8.5.2 Corporate Summary
8.5.3 Product Offerings for Global CRISPR Technology Market
8.5.4 Global Presence
8.5.5 Recent Developments
8.5.6 SWOT Analysis
8.6 EdiGene, Inc.
8.6.1 Overview
8.6.2 Corporate Summary
8.6.3 Product Offerings for Global CRISPR Technology Market
8.6.4 Recent Developments
8.6.5 SWOT Analysis
8.7 GeneCopoeia, Inc.
8.7.1 Overview
8.7.2 Corporate Summary
8.7.3 Product Offerings for Global CRISPR Technology Market
8.7.4 SWOT Analysis
8.8 Genedata AG
8.8.1 Overview
8.8.2 Corporate Summary
8.8.3 Product Offerings for Global CRISPR Technology Market
8.8.4 Recent Developments
8.8.5 SWOT Analysis
8.9 GeneScript
8.9.1 Overview
8.9.2 Overall Product Portfolio
8.9.3 Product Offerings for Global CRISPR Technology Market
8.9.4 Financials
8.9.4.1 Financial Summary
8.9.5 Global Presence
8.9.6 Recent Developments
8.9.7 SWOT Analysis
8.10 Integrated DNA Technologies (IDT), Inc.
8.10.1 Overview
8.10.2 Corporate Summary
8.10.3 Product Offerings for Global CRISPR Technology Market
8.10.4 Recent Developments
8.10.5 SWOT Analysis
8.11 Mirus Bio LLC
8.11.1 Overview
8.11.2 Corporate Summary
8.11.3 Product Offerings for Global CRISPR Technology Market
8.11.4 Recent Developments
8.11.5 SWOT Analysis
8.12 New England Biolabs
8.12.1 Overview
8.12.2 Corporate Summary
8.12.3 Product Offerings for Global CRISPR Technology Market
8.12.4 SWOT Analysis
8.13 OriGene Technologies, Inc.
8.13.1 Overview
8.13.2 Corporate Summary
8.13.3 Product Offerings for Global CRISPR Technology Market
8.13.4 Recent Developments
8.13.5 SWOT Analysis
8.14 Oxford Genetics Ltd.
8.14.1 Overview
8.14.2 Corporate Summary
8.14.3 Product Offerings for Global CRISPR Technology Market
8.14.4 Recent Developments
8.14.5 SWOT Analysis
8.15 Rockland Immunochemicals, Inc.
8.15.1 Overview
8.15.2 Corporate Summary
8.15.3 Product Offerings for Global CRISPR Technology Market
8.15.4 SWOT Analysis
8.16 Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
8.16.1 Overview
8.16.2 Overall Product Portfolio
8.16.3 Product Offerings for Global CRISPR Technology Market
8.16.4 Financials
8.16.4.1 Financial Summary
8.16.5 Global Presence
8.16.6 Recent Developments
8.16.7 SWOT Analysis
8.17 Synthego Corporation
8.17.1 Overview
8.17.2 Corporate Summary
8.17.3 Product Offerings for Global CRISPR Technology Market
8.17.4 Recent Developments
8.17.5 SWOT Analysis
8.18 System Biosciences, LLC
8.18.1 Overview
8.18.2 Corporate Summary
8.18.3 Product Offerings for Global CRISPR Technology Market
8.18.4 SWOT Analysis
8.19 Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
8.19.1 Overview
8.19.2 Overall Product Portfolio
8.19.3 Product Offerings for Global CRISPR Technology Market
8.19.4 Financials
8.19.4.1 Financial Summary
8.19.5 Global Presence
8.19.6 Recent Developments
8.19.7 SWOT Analysis
8.20 Thermo Fisher Scientific Inc.
8.20.1 Overview
8.20.2 Overall Product Portfolio
8.20.3 Product Offerings for Global CRISPR Technology Market
8.20.4 Financials
8.20.4.1 Financial Summary
8.20.5 Global Presence
8.20.6 Recent Developments
8.20.7 SWOT Analysis
8.21 transOMIC technologies inc.
8.21.1 Overview
8.21.2 Corporate Summary
8.21.3 Product Offerings for Global CRISPR Technology Market
8.21.4 Recent Developments
8.21.5 SWOT Analysis
8.22 Transposagen Biopharmaceuticals
8.22.1 Overview
8.22.2 Corporate Summary
8.22.3 Product Offerings for Global CRISPR Technology Market
8.22.4 SWOT Analysis
9 REPORT SCOPE & METHODOLOGY
9.1 Scope of the Report
9.2 Global CRISPR Technology Market Segmentation
9.3 Research Methodology
9.3.1 Primary Research
9.3.2 Secondary Research
9.3.3 Key Data Points from Primary Sources
9.3.4 Key Data Points from Secondary Sources
9.3.5 Data Triangulation
9.3.6 Top-Down Approach (Segment wise Analysis)
9.3.7 Bottom-Up Approach (Segmental Analysis)
9.4 Assumptions and Limitations
9.5 Data and Prediction Modelling
I Annexure 1: Recent Key Developments (2014 – 2018) and Patent Landscape
II Annexure 2: Product Mapping and Pricing Analysis
1 MARKET OVERVIEW
1.1 Introduction
1.2 CRISPR Technology Approach
1.3 Evolution of CRISPR Technology
1.4 CRISPR Technology: Areas of Interest
1.5 CRISPR Technology: Future Potential
1.6 Global Market
1.7 Assumptions and Limitations
2 MARKET DYNAMICS
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.4 Market Restraints
2.5 Market Opportunities
3 COMPETITIVE LANDSCAPE
3.1 Introduction
3.2 Key Developments and Strategies
3.3 Product Launches and Enhancements
3.4 Joint Ventures, Partnerships and Collaborations
3.5 Mergers and Acquisitions
3.6 Business Expansions, Awards, Recognitions, Certifications and Others
3.7 Industry Attractiveness
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Threat of New Entrants
3.7.4 Threat of Substitute Products
3.7.5 Intensity of Competitive Rivalry
3.8 Pipeline Analysis
4 INDUSTRY INSIGHTS
4.1 Introduction
4.2 Patent Analysis
4.3 Funding Scenario
4.3.1 Funding Scenario: Public Companies
4.3.2 Funding Scenario: Private Companies
4.3.3 Funding Scenario: Investments by Government Organizations
4.4 Legal Requirements and Regulations
4.5 List of Regulatory Bodies
5 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT
5.1 Overview
5.2 Designing Tools
5.3 Library
5.4 Control Kits
5.5 Plasmids
5.6 Vectors
5.7 Proteins
5.7.1 Cas9
5.7.2 Cpf1
5.7.3 Others
5.8 Grna
5.9 Others
6 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION
6.1 Overview
6.2 Biological Research
6.3 Agricultural Biotech
6.4 Industrial Biotech
6.5 Therapeutics and Drug Discovery
7 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION
7.1 Overview
7.2 Global Insights
7.3 North America
7.3.1 North America Market Dynamics
7.3.2 North America Market, by Country
7.3.2.1 The U.S.
7.3.2.2 Canada
7.4 Europe
7.4.1 Europe Market Dynamics
7.4.2 Europe Market, by Country
7.4.2.1 The U.K.
7.4.2.2 Germany
7.4.2.3 France
7.4.2.4 Spain
7.4.2.5 Italy
7.4.2.6 Switzerland
7.4.2.7 Rest of the Europe
7.5 Asia Pacific
7.5.1 Asia Pacific Market Dynamics
7.5.2 Asia Pacific, by Country
7.5.2.1 Japan
7.5.2.2 China
7.5.2.3 South Korea
7.5.2.4 Singapore
7.5.2.5 India
7.5.2.6 Rest of Asia Pacific
7.6 Rest of the World
8 COMPANY PROFILES
8.1 Agilent Technologies, Inc.
8.1.1 Overview
8.1.2 Overall Product Portfolio
8.1.3 Product Offerings for Global CRISPR Technology Market
8.1.4 Financials
8.1.4.1 Financial Summary
8.1.5 Global Presence
8.1.6 Recent Developments
8.1.7 SWOT Analysis
8.2 Applied StemCell, Inc.
8.2.1 Overview
8.2.2 Corporate Summary
8.2.3 Product Offerings for Global CRISPR Technology Market
8.2.4 Recent Developments
8.2.5 SWOT Analysis
8.3 Cellecta, Inc.
8.3.1 Overview
8.3.2 Corporate Summary
8.3.3 Product Offerings for Global CRISPR Technology Market
8.3.4 SWOT Analysis
8.4 Dharmacon, Inc.
8.4.1 Overview
8.4.2 Overall Product Portfolio
8.4.3 Product Offerings for Global CRISPR Technology Market
8.4.4 Financials
8.4.4.1 Financial Summary
8.4.5 Global Presence
8.4.6 Recent Developments
8.4.7 SWOT Analysis
8.5 DiaCarta, Inc.
8.5.1 Overview
8.5.2 Corporate Summary
8.5.3 Product Offerings for Global CRISPR Technology Market
8.5.4 Global Presence
8.5.5 Recent Developments
8.5.6 SWOT Analysis
8.6 EdiGene, Inc.
8.6.1 Overview
8.6.2 Corporate Summary
8.6.3 Product Offerings for Global CRISPR Technology Market
8.6.4 Recent Developments
8.6.5 SWOT Analysis
8.7 GeneCopoeia, Inc.
8.7.1 Overview
8.7.2 Corporate Summary
8.7.3 Product Offerings for Global CRISPR Technology Market
8.7.4 SWOT Analysis
8.8 Genedata AG
8.8.1 Overview
8.8.2 Corporate Summary
8.8.3 Product Offerings for Global CRISPR Technology Market
8.8.4 Recent Developments
8.8.5 SWOT Analysis
8.9 GeneScript
8.9.1 Overview
8.9.2 Overall Product Portfolio
8.9.3 Product Offerings for Global CRISPR Technology Market
8.9.4 Financials
8.9.4.1 Financial Summary
8.9.5 Global Presence
8.9.6 Recent Developments
8.9.7 SWOT Analysis
8.10 Integrated DNA Technologies (IDT), Inc.
8.10.1 Overview
8.10.2 Corporate Summary
8.10.3 Product Offerings for Global CRISPR Technology Market
8.10.4 Recent Developments
8.10.5 SWOT Analysis
8.11 Mirus Bio LLC
8.11.1 Overview
8.11.2 Corporate Summary
8.11.3 Product Offerings for Global CRISPR Technology Market
8.11.4 Recent Developments
8.11.5 SWOT Analysis
8.12 New England Biolabs
8.12.1 Overview
8.12.2 Corporate Summary
8.12.3 Product Offerings for Global CRISPR Technology Market
8.12.4 SWOT Analysis
8.13 OriGene Technologies, Inc.
8.13.1 Overview
8.13.2 Corporate Summary
8.13.3 Product Offerings for Global CRISPR Technology Market
8.13.4 Recent Developments
8.13.5 SWOT Analysis
8.14 Oxford Genetics Ltd.
8.14.1 Overview
8.14.2 Corporate Summary
8.14.3 Product Offerings for Global CRISPR Technology Market
8.14.4 Recent Developments
8.14.5 SWOT Analysis
8.15 Rockland Immunochemicals, Inc.
8.15.1 Overview
8.15.2 Corporate Summary
8.15.3 Product Offerings for Global CRISPR Technology Market
8.15.4 SWOT Analysis
8.16 Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
8.16.1 Overview
8.16.2 Overall Product Portfolio
8.16.3 Product Offerings for Global CRISPR Technology Market
8.16.4 Financials
8.16.4.1 Financial Summary
8.16.5 Global Presence
8.16.6 Recent Developments
8.16.7 SWOT Analysis
8.17 Synthego Corporation
8.17.1 Overview
8.17.2 Corporate Summary
8.17.3 Product Offerings for Global CRISPR Technology Market
8.17.4 Recent Developments
8.17.5 SWOT Analysis
8.18 System Biosciences, LLC
8.18.1 Overview
8.18.2 Corporate Summary
8.18.3 Product Offerings for Global CRISPR Technology Market
8.18.4 SWOT Analysis
8.19 Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
8.19.1 Overview
8.19.2 Overall Product Portfolio
8.19.3 Product Offerings for Global CRISPR Technology Market
8.19.4 Financials
8.19.4.1 Financial Summary
8.19.5 Global Presence
8.19.6 Recent Developments
8.19.7 SWOT Analysis
8.20 Thermo Fisher Scientific Inc.
8.20.1 Overview
8.20.2 Overall Product Portfolio
8.20.3 Product Offerings for Global CRISPR Technology Market
8.20.4 Financials
8.20.4.1 Financial Summary
8.20.5 Global Presence
8.20.6 Recent Developments
8.20.7 SWOT Analysis
8.21 transOMIC technologies inc.
8.21.1 Overview
8.21.2 Corporate Summary
8.21.3 Product Offerings for Global CRISPR Technology Market
8.21.4 Recent Developments
8.21.5 SWOT Analysis
8.22 Transposagen Biopharmaceuticals
8.22.1 Overview
8.22.2 Corporate Summary
8.22.3 Product Offerings for Global CRISPR Technology Market
8.22.4 SWOT Analysis
9 REPORT SCOPE & METHODOLOGY
9.1 Scope of the Report
9.2 Global CRISPR Technology Market Segmentation
9.3 Research Methodology
9.3.1 Primary Research
9.3.2 Secondary Research
9.3.3 Key Data Points from Primary Sources
9.3.4 Key Data Points from Secondary Sources
9.3.5 Data Triangulation
9.3.6 Top-Down Approach (Segment wise Analysis)
9.3.7 Bottom-Up Approach (Segmental Analysis)
9.4 Assumptions and Limitations
9.5 Data and Prediction Modelling
I Annexure 1: Recent Key Developments (2014 – 2018) and Patent Landscape
II Annexure 2: Product Mapping and Pricing Analysis
LIST OF TABLES
1 GLOBAL CRISPR TECHNOLOGY MARKET (2017 & 2027)
2 IMPACT ANALYSIS OF MARKET DYNAMICS
3 PIPELINE ANALYSIS OF BIOPHARMACEUTICAL COMPANIES USING CRISPR TECHNOLOGY
4 FUNDING SCENARIO OF PUBLIC COMPANIES
5 FUNDING SCENARIO OF PRIVATE COMPANIES
6 FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS
7 LIST OF REGULATORY BODIES
8 EUROPE CRISPR TECHNOLOGY MARKET, BY COUNTRY, $MILLION (2017-2027)
9 ASIA PACIFIC CRISPR TECHNOLOGY MARKET, BY COUNTRY, $MILLION (2017-2027)
10 AGILENT TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
11 APPLIED STEMCELL, INC.: OTHER DEVELOPMENTS
12 APPLIED STEMCELL, INC.: MERGER AND ACQUISITION
13 HORIZON DISCOVERY PLC: PRODUCT DEVELOPMENTS
14 HORIZON DISCOVERY PLC: MERGER, ACQUISITION & COLLABORATION
15 EDIGENE, INC.: AGREEMENTS AND OTHER DEVELOPMENTS
16 GENEDATA AG: AGREEMENTS AND COLLABORATION
17 GENEDATA AG: PRODUCT DEVELOPMENTS
18 GENEDATA AG: OTHER DEVELOPMENTS
19 GENSCRIPT: PRODUCT DEVELOPMENTS
20 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
21 INTEGRATED DNA TECHNOLOGIES, INC.: MERGER AND ACQUISITION
22 MIRUS BIO LLC: PRODUCT DEVELOPMENTS
23 ORIGENE TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
24 OXFORD GENETICS LTD.: AGREEMENTS AND OTHER DEVELOPMENTS
25 MERCK KGAA: PARTNERSHIPS, COLLABORATION, ACQUISITION AND JOINT VENTURE
26 MERCK KGAA: OTHER DEVELOPMENTS
27 SYNTHEGO CORPORATION: PRODUCT DEVELOPMENTS
28 SYNTHEGO CORPORATION : OTHER DEVELOPMENTS
29 TAKARA BIO USA INC.: PRODUCT DEVELOPMENTS
30 TAKARA BIO USA INC.: MERGER AND ACQUISITION
31 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS
32 THERMO FISHER SCIENTIFIC INC.: MERGER AND ACQUISITION
33 TRANSOMIC TECHNOLOGIES INC.: PRODUCT DEVELOPMENTS
1 GLOBAL CRISPR TECHNOLOGY MARKET (2017 & 2027)
2 IMPACT ANALYSIS OF MARKET DYNAMICS
3 PIPELINE ANALYSIS OF BIOPHARMACEUTICAL COMPANIES USING CRISPR TECHNOLOGY
4 FUNDING SCENARIO OF PUBLIC COMPANIES
5 FUNDING SCENARIO OF PRIVATE COMPANIES
6 FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS
7 LIST OF REGULATORY BODIES
8 EUROPE CRISPR TECHNOLOGY MARKET, BY COUNTRY, $MILLION (2017-2027)
9 ASIA PACIFIC CRISPR TECHNOLOGY MARKET, BY COUNTRY, $MILLION (2017-2027)
10 AGILENT TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
11 APPLIED STEMCELL, INC.: OTHER DEVELOPMENTS
12 APPLIED STEMCELL, INC.: MERGER AND ACQUISITION
13 HORIZON DISCOVERY PLC: PRODUCT DEVELOPMENTS
14 HORIZON DISCOVERY PLC: MERGER, ACQUISITION & COLLABORATION
15 EDIGENE, INC.: AGREEMENTS AND OTHER DEVELOPMENTS
16 GENEDATA AG: AGREEMENTS AND COLLABORATION
17 GENEDATA AG: PRODUCT DEVELOPMENTS
18 GENEDATA AG: OTHER DEVELOPMENTS
19 GENSCRIPT: PRODUCT DEVELOPMENTS
20 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
21 INTEGRATED DNA TECHNOLOGIES, INC.: MERGER AND ACQUISITION
22 MIRUS BIO LLC: PRODUCT DEVELOPMENTS
23 ORIGENE TECHNOLOGIES, INC.: PRODUCT DEVELOPMENTS
24 OXFORD GENETICS LTD.: AGREEMENTS AND OTHER DEVELOPMENTS
25 MERCK KGAA: PARTNERSHIPS, COLLABORATION, ACQUISITION AND JOINT VENTURE
26 MERCK KGAA: OTHER DEVELOPMENTS
27 SYNTHEGO CORPORATION: PRODUCT DEVELOPMENTS
28 SYNTHEGO CORPORATION : OTHER DEVELOPMENTS
29 TAKARA BIO USA INC.: PRODUCT DEVELOPMENTS
30 TAKARA BIO USA INC.: MERGER AND ACQUISITION
31 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS
32 THERMO FISHER SCIENTIFIC INC.: MERGER AND ACQUISITION
33 TRANSOMIC TECHNOLOGIES INC.: PRODUCT DEVELOPMENTS
LIST OF FIGURES
1 IMPACT OF MARKET DRIVERS AND MARKET RESTRAINTS
2 MARKET STATISTICS
3 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT ($MILLION)
4 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT, 2017
5 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT, 2027
6 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2017
7 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2027
8 GLOBAL CRISPR TECHNOLOGY MARKET VALUE, BY REGION, 2017 & 2027 ($MILLION)
9 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION, 2017
10 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION, 2027
11 ADVANTAGES OF CRISPR TECHNOLOGY
12 CRISPR TECHNOLOGY APPROACH
13 EVOLUTION OF CRISPR TECHNOLOGY
14 CRISPR TECHNOLOGY: AREAS OF INTEREST
15 FUTURE POTENTIAL OF CRISPR TECHNOLOGY
16 GLOBAL CRSIPR TECHNOLOGY MARKET (2017-2027)
17 MARKET DYNAMICS
18 COMPETITIVE LANDSCAPE (JANUARY 2014-FEBRUARY 2018)
19 SHARE OF KEY DEVELOPMENTS AND STRATEGIES (JANUARY 2014-FEBRUARY 2018)
20 PRODUCT LAUNCH SHARE, BY COMPANIES
21 JOINT VENTURES, PARTNERSHIPS, AND COLLABORATIONS SHARE, BY COMPANIES
22 PORTER’S FIVE FORCES ANALYSIS
23 INDUSTRY INSIGHTS (JANUARY 2014-FEBRUARY 2018)
24 FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION
25 CRISPR TECHNOLOGY MARKET, BY PRODUCT
26 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT (2017-2027)
27 DIFFERENT DESIGNING TOOLS
28 GLOBAL CRISPR TECHNOLOGY MARKET, BY DESIGNING TOOLS (2017-2027)
29 TYPES OF LIBRARY
30 GLOBAL CRISPR TECHNOLOGY MARKET, BY LIBRARY (2017-2027)
31 TYPES OF CONTROLS
32 GLOBAL CRISPR TECHNOLOGY MARKET, BY CONTROL KITS (2017-2027)
33 TYPES OF PLASMIDS
34 GLOBAL CRISPR TECHNOLOGY MARKET, BY PLASMIDS (2017-2027)
35 TYPES OF VECTORS
36 GLOBAL CRISPR TECHNOLOGY MARKET, BY VECTORS (2017-2027)
37 TYPES OF PROTEINS
38 GLOBAL CRISPR TECHNOLOGY MARKET, BY PROTEINS (2017-2027)
39 GLOBAL CRISPR TECHNOLOGY MARKET, BY CAS9 (2017-2027)
40 GLOBAL CRISPR TECHNOLOGY MARKET, BY CPF1 (2017-2027)
41 GLOBAL CRISPR TECHNOLOGY MARKET, BY OTHERS (2017-2027)
42 GLOBAL CRISPR TECHNOLOGY MARKET, BY GRNA (2017-2027)
43 GLOBAL CRISPR TECHNOLOGY MARKET, BY OTHERS (2017-2027)
44 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY APPLICATION, 2017
45 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY APPLICATION, 2017
46 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION (2017-2027)
47 APPLICATION OF CRISPR TECHNOLOGY IN BIOLOGICAL RESEARCH
48 GLOBAL CRISPR TECHNOLOGY MARKET, BY BIOLOGICAL RESEARCH (2017-2027)
49 APPLICATION OF CRISPR TECHNOLOGY IN AGRICULTURAL RESEARCH
50 GLOBAL CRISPR TECHNOLOGY MARKET, BY AGRICULTURAL BIOTECH (2017-2027)
51 GLOBAL CRISPR TECHNOLOGY MARKET, BY INDUSTRIAL BIOTECH (2017-2027)
52 GLOBAL CRISPR TECHNOLOGY MARKET, BY THERAPEUTICS AND DRUG DISCOVERY (2017-2027)
53 GLOBAL CRSIPR TECHNOLOGY MARKET, BY REGION (2017-2027)
54 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY REGION (2017)
55 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY REGION (2027)
56 NORTH AMERICA CRISPR TECHNOLOGY MARKET (2017-2027)
57 NORTH AMERICA CRISPR TECHNOLOGY MARKET, BY COUNTRY (2017-2027)
58 THE U.S. CRISPR TECHNOLOGY MARKET (2017-2027)
59 CANADA CRISPR TECHNOLOGY MARKET (2017-2027)
60 EUROPE CRISPR TECHNOLOGY MARKET (2017-2027)
61 THE U.K. CRISPR TECHNOLOGY MARKET (2017-2027)
62 GERMANY CRISPR TECHNOLOGY MARKET (2017-2027)
63 FRANCE CRISPR TECHNOLOGY MARKET (2017-2027)
64 SPAIN CRISPR TECHNOLOGY MARKET (2017-2027)
65 ITALY CRISPR TECHNOLOGY MARKET (2017-2027)
66 SWITZERLAND CRISPR TECHNOLOGY MARKET (2017-2027)
67 REST OF THE EUROPE CRISPR TECHNOLOGY MARKET (2017-2027)
68 ASIA PACIFIC CRISPR TECHNOLOGY MARKET (2017-2027)
69 JAPAN CRISPR TECHNOLOGY MARKET (2017-2027)
70 CHINA CRISPR TECHNOLOGY MARKET (2017-2027)
71 SOUTH KOREA CRISPR TECHNOLOGY MARKET (2017-2027)
72 SINGAPORE CRISPR TECHNOLOGY MARKET (2017-2027)
73 INDIA CRISPR TECHNOLOGY MARKET (2017-2027)
74 REST OF ASIA PACIFIC CRISPR TECHNOLOGY MARKET (2017-2027)
75 REST OF THE WORLD CRISPR TECHNOLOGY MARKET (2017-2027)
76 AGILENT TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
77 AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
78 AGILENT TECHNOLOGIES, INC.: OVERALL FINANCIALS (2014-2017)
79 AGILENT TECHNOLOGIES, INC.: REVENUE BY BUSINESS SEGMENT (2014-2017)
80 AGILENT TECHNOLOGIES, INC.: REVENUE BY REGION (2014-2017)
81 AGILENT TECHNOLOGIES, INC.: GLOBAL PRESENCE
82 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
83 APPLIED STEMCELL, INC.: OVERALL PRODUCT PORTFOLIO
84 APPLIED STEMCELL, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
85 APPLIED STEMCELL, INC.: SWOT ANALYSIS
86 CELLECTA, INC.: OVERALL PRODUCT PORTFOLIO
87 CELLECTA, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
88 CELLECTA, INC.: SWOT ANALYSIS
89 HORIZON DISCOVERY PLC: OVERALL PRODUCT PORTFOLIO
90 HORIZON DISCOVERY PLC (DHARMACON, INC.): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
91 HORIZON DISCOVERY PLC: OVERALL FINANCIALS (2014-2016)
92 HORIZON DISCOVERY PLC: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
93 HORIZON DISCOVERY PLC: NET REVENUE BY REGION (2014-2016)
94 HORIZON DISCOVERY PLC: GLOBAL PRESENCE
95 HORIZON DISCOVERY PLC: SWOT ANALYSIS
96 EDIGENE, INC.: OVERALL PRODUCT PORTFOLIO
97 EDIGENE, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
98 EDIGENE, INC.: SWOT ANALYSIS
99 GENECOPOEIA, INC.: OVERALL PRODUCT PORTFOLIO
100 GENECOPOEIA, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
101 GENECOPOEIA, INC.: SWOT ANALYSIS
102 GENEDATA AG: OVERALL PRODUCT PORTFOLIO
103 GENEDATA AG: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
104 GENEDATA AG: SWOT ANALYSIS
105 GENSCRIPT: OVERALL PRODUCT PORTFOLIO
106 GENSCRIPT: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
107 GENSCRIPT: OVERALL FINANCIALS (2014-2016)
108 GENSCRIPT: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
109 GENSCRIPT: NET REVENUE BY REGION (2014-2016)
110 GENSCRIPT: GLOBAL PRESENCE
111 GENSCRIPT: SWOT ANALYSIS
112 INTEGRATED DNA TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
113 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
114 INTEGRATED DNA TECHNOLOGIES, INC.: SWOT ANALYSIS
115 MIRUS BIO LLC : OVERALL PRODUCT PORTFOLIO
116 MIRUS BIO LLC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
117 MIRUS BIO LLC: SWOT ANALYSIS
118 NEW ENGLAND BIOLABS: OVERALL PRODUCT PORTFOLIO
119 NEW ENGLAND BIOLABS: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
120 NEW ENGLAND BIOLABS: SWOT ANALYSIS
121 ORIGENE TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
122 ORIGENE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
123 ORIGENE TECHNOLOGIES, INC.: SWOT ANALYSIS
124 OXFORD GENETICS LTD.: OVERALL PRODUCT PORTFOLIO
125 OXFORD GENETICS LTD. : PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
126 OXFORD GENETICS LTD.: SWOT ANALYSIS
127 ROCKLAND IMMUNOCHEMICALS, INC: OVERALL PRODUCT PORTFOLIO
128 ROCKLAND IMMUNOCHEMICALS, INC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
129 ROCKLAND IMMUNOCHEMICALS, INC: SWOT ANALYSIS
130 MERCK KGAA: OVERALL PRODUCT PORTFOLIO
131 MERCK KGAA (SIGMA ALDRICH CORPORATION): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
132 MERCK KGAA: OVERALL FINANCIALS, (2014-2016)
133 MERCK KGAA: NET REVENUE BY BUSINESS SEGMENTS, (2014-2016)
134 MERCK KGAA: NET REVENUE BY GEOGRAPHY, (2014)
135 MERCK KGAA: NET REVENUE BY GEOGRAPHY, (2015-2016)
136 MERCK KGAA: GLOBAL PRESENCE
137 MERCK KGAA: SWOT ANALYSIS
138 SYNTHEGO CORPORATION: OVERALL PRODUCT PORTFOLIO
139 SYNTHEGO CORPORATION: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
140 SYNTHEGO CORPORATION: SWOT ANALYSIS
141 SYSTEM BIOSCIENCES, LLC: OVERALL PRODUCT PORTFOLIO
142 SYSTEM BIOSCIENCES, LLC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
143 SYSTEM BIOSCIENCES, LLC: SWOT ANALYSIS
144 TAKARA BIO INC. : OVERALL PRODUCT PORTFOLIO
145 TAKARA BIO INC. (TAKARA BIO USA INC.): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
146 TAKAR BIO INC.: OVERALL FINANCIALS (2014-2017)
147 TAKARA BIO INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
148 TAKARA BIO INC.: NET REVENUE BY REGION (2014-2017)
149 TAKARA BIO INC.: GLOBAL PRESENCE
150 TAKARA BIO INC.: SWOT ANALYSIS
151 THERMO FISHER SCIENTIFIC INC.: OVERALL PRODUCT PORTFOLIO
152 THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
153 THERMO FISHER SCIENTIFIC INC.: OVERALL FINANCIALS (2014-2017)
154 THERMO FISHER SCIENTIFIC INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
155 THERMO FISHER SCIENTIFIC INC.: NET REVENUE BY REGION (2014-2016)
156 THERMO FISHER SCIENTIFIC INC.: GLOBAL PRESENCE
157 THERMO FISHER SCIENTIFIC INC.- SWOT ANALYSIS
158 TRANSOMIC TECHNOLOGIES INC.: OVERALL PRODUCT PORTFOLIO
159 TRANSOMIC TECHNOLOGIES INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
160 TRANSOMIC TECHNOLOGIES INC.: SWOT ANALYSIS
161 TRANSPOSAGEN BIOPHARMACEUTICALS: OVERALL PRODUCT PORTFOLIO
162 TRANSPOSAGEN BIOPHARMACEUTICALS: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
163 TRANSPOSAGEN BIOPHARMACEUTICALS: SWOT ANALYSIS
164 GLOBAL CRISPR TECHNOLOGY MARKET SEGMENTATION
165 CONSIDERED FACTORS FOR DATA PREDICTION & MODELING
1 IMPACT OF MARKET DRIVERS AND MARKET RESTRAINTS
2 MARKET STATISTICS
3 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT ($MILLION)
4 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT, 2017
5 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT, 2027
6 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2017
7 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION, 2027
8 GLOBAL CRISPR TECHNOLOGY MARKET VALUE, BY REGION, 2017 & 2027 ($MILLION)
9 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION, 2017
10 GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION, 2027
11 ADVANTAGES OF CRISPR TECHNOLOGY
12 CRISPR TECHNOLOGY APPROACH
13 EVOLUTION OF CRISPR TECHNOLOGY
14 CRISPR TECHNOLOGY: AREAS OF INTEREST
15 FUTURE POTENTIAL OF CRISPR TECHNOLOGY
16 GLOBAL CRSIPR TECHNOLOGY MARKET (2017-2027)
17 MARKET DYNAMICS
18 COMPETITIVE LANDSCAPE (JANUARY 2014-FEBRUARY 2018)
19 SHARE OF KEY DEVELOPMENTS AND STRATEGIES (JANUARY 2014-FEBRUARY 2018)
20 PRODUCT LAUNCH SHARE, BY COMPANIES
21 JOINT VENTURES, PARTNERSHIPS, AND COLLABORATIONS SHARE, BY COMPANIES
22 PORTER’S FIVE FORCES ANALYSIS
23 INDUSTRY INSIGHTS (JANUARY 2014-FEBRUARY 2018)
24 FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION
25 CRISPR TECHNOLOGY MARKET, BY PRODUCT
26 GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT (2017-2027)
27 DIFFERENT DESIGNING TOOLS
28 GLOBAL CRISPR TECHNOLOGY MARKET, BY DESIGNING TOOLS (2017-2027)
29 TYPES OF LIBRARY
30 GLOBAL CRISPR TECHNOLOGY MARKET, BY LIBRARY (2017-2027)
31 TYPES OF CONTROLS
32 GLOBAL CRISPR TECHNOLOGY MARKET, BY CONTROL KITS (2017-2027)
33 TYPES OF PLASMIDS
34 GLOBAL CRISPR TECHNOLOGY MARKET, BY PLASMIDS (2017-2027)
35 TYPES OF VECTORS
36 GLOBAL CRISPR TECHNOLOGY MARKET, BY VECTORS (2017-2027)
37 TYPES OF PROTEINS
38 GLOBAL CRISPR TECHNOLOGY MARKET, BY PROTEINS (2017-2027)
39 GLOBAL CRISPR TECHNOLOGY MARKET, BY CAS9 (2017-2027)
40 GLOBAL CRISPR TECHNOLOGY MARKET, BY CPF1 (2017-2027)
41 GLOBAL CRISPR TECHNOLOGY MARKET, BY OTHERS (2017-2027)
42 GLOBAL CRISPR TECHNOLOGY MARKET, BY GRNA (2017-2027)
43 GLOBAL CRISPR TECHNOLOGY MARKET, BY OTHERS (2017-2027)
44 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY APPLICATION, 2017
45 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY APPLICATION, 2017
46 GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION (2017-2027)
47 APPLICATION OF CRISPR TECHNOLOGY IN BIOLOGICAL RESEARCH
48 GLOBAL CRISPR TECHNOLOGY MARKET, BY BIOLOGICAL RESEARCH (2017-2027)
49 APPLICATION OF CRISPR TECHNOLOGY IN AGRICULTURAL RESEARCH
50 GLOBAL CRISPR TECHNOLOGY MARKET, BY AGRICULTURAL BIOTECH (2017-2027)
51 GLOBAL CRISPR TECHNOLOGY MARKET, BY INDUSTRIAL BIOTECH (2017-2027)
52 GLOBAL CRISPR TECHNOLOGY MARKET, BY THERAPEUTICS AND DRUG DISCOVERY (2017-2027)
53 GLOBAL CRSIPR TECHNOLOGY MARKET, BY REGION (2017-2027)
54 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY REGION (2017)
55 GLOBAL CRISPR TECHNOLOGY MARKET SHARE, BY REGION (2027)
56 NORTH AMERICA CRISPR TECHNOLOGY MARKET (2017-2027)
57 NORTH AMERICA CRISPR TECHNOLOGY MARKET, BY COUNTRY (2017-2027)
58 THE U.S. CRISPR TECHNOLOGY MARKET (2017-2027)
59 CANADA CRISPR TECHNOLOGY MARKET (2017-2027)
60 EUROPE CRISPR TECHNOLOGY MARKET (2017-2027)
61 THE U.K. CRISPR TECHNOLOGY MARKET (2017-2027)
62 GERMANY CRISPR TECHNOLOGY MARKET (2017-2027)
63 FRANCE CRISPR TECHNOLOGY MARKET (2017-2027)
64 SPAIN CRISPR TECHNOLOGY MARKET (2017-2027)
65 ITALY CRISPR TECHNOLOGY MARKET (2017-2027)
66 SWITZERLAND CRISPR TECHNOLOGY MARKET (2017-2027)
67 REST OF THE EUROPE CRISPR TECHNOLOGY MARKET (2017-2027)
68 ASIA PACIFIC CRISPR TECHNOLOGY MARKET (2017-2027)
69 JAPAN CRISPR TECHNOLOGY MARKET (2017-2027)
70 CHINA CRISPR TECHNOLOGY MARKET (2017-2027)
71 SOUTH KOREA CRISPR TECHNOLOGY MARKET (2017-2027)
72 SINGAPORE CRISPR TECHNOLOGY MARKET (2017-2027)
73 INDIA CRISPR TECHNOLOGY MARKET (2017-2027)
74 REST OF ASIA PACIFIC CRISPR TECHNOLOGY MARKET (2017-2027)
75 REST OF THE WORLD CRISPR TECHNOLOGY MARKET (2017-2027)
76 AGILENT TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
77 AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
78 AGILENT TECHNOLOGIES, INC.: OVERALL FINANCIALS (2014-2017)
79 AGILENT TECHNOLOGIES, INC.: REVENUE BY BUSINESS SEGMENT (2014-2017)
80 AGILENT TECHNOLOGIES, INC.: REVENUE BY REGION (2014-2017)
81 AGILENT TECHNOLOGIES, INC.: GLOBAL PRESENCE
82 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
83 APPLIED STEMCELL, INC.: OVERALL PRODUCT PORTFOLIO
84 APPLIED STEMCELL, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
85 APPLIED STEMCELL, INC.: SWOT ANALYSIS
86 CELLECTA, INC.: OVERALL PRODUCT PORTFOLIO
87 CELLECTA, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
88 CELLECTA, INC.: SWOT ANALYSIS
89 HORIZON DISCOVERY PLC: OVERALL PRODUCT PORTFOLIO
90 HORIZON DISCOVERY PLC (DHARMACON, INC.): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
91 HORIZON DISCOVERY PLC: OVERALL FINANCIALS (2014-2016)
92 HORIZON DISCOVERY PLC: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
93 HORIZON DISCOVERY PLC: NET REVENUE BY REGION (2014-2016)
94 HORIZON DISCOVERY PLC: GLOBAL PRESENCE
95 HORIZON DISCOVERY PLC: SWOT ANALYSIS
96 EDIGENE, INC.: OVERALL PRODUCT PORTFOLIO
97 EDIGENE, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
98 EDIGENE, INC.: SWOT ANALYSIS
99 GENECOPOEIA, INC.: OVERALL PRODUCT PORTFOLIO
100 GENECOPOEIA, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
101 GENECOPOEIA, INC.: SWOT ANALYSIS
102 GENEDATA AG: OVERALL PRODUCT PORTFOLIO
103 GENEDATA AG: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
104 GENEDATA AG: SWOT ANALYSIS
105 GENSCRIPT: OVERALL PRODUCT PORTFOLIO
106 GENSCRIPT: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
107 GENSCRIPT: OVERALL FINANCIALS (2014-2016)
108 GENSCRIPT: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
109 GENSCRIPT: NET REVENUE BY REGION (2014-2016)
110 GENSCRIPT: GLOBAL PRESENCE
111 GENSCRIPT: SWOT ANALYSIS
112 INTEGRATED DNA TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
113 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
114 INTEGRATED DNA TECHNOLOGIES, INC.: SWOT ANALYSIS
115 MIRUS BIO LLC : OVERALL PRODUCT PORTFOLIO
116 MIRUS BIO LLC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
117 MIRUS BIO LLC: SWOT ANALYSIS
118 NEW ENGLAND BIOLABS: OVERALL PRODUCT PORTFOLIO
119 NEW ENGLAND BIOLABS: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
120 NEW ENGLAND BIOLABS: SWOT ANALYSIS
121 ORIGENE TECHNOLOGIES, INC.: OVERALL PRODUCT PORTFOLIO
122 ORIGENE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
123 ORIGENE TECHNOLOGIES, INC.: SWOT ANALYSIS
124 OXFORD GENETICS LTD.: OVERALL PRODUCT PORTFOLIO
125 OXFORD GENETICS LTD. : PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
126 OXFORD GENETICS LTD.: SWOT ANALYSIS
127 ROCKLAND IMMUNOCHEMICALS, INC: OVERALL PRODUCT PORTFOLIO
128 ROCKLAND IMMUNOCHEMICALS, INC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
129 ROCKLAND IMMUNOCHEMICALS, INC: SWOT ANALYSIS
130 MERCK KGAA: OVERALL PRODUCT PORTFOLIO
131 MERCK KGAA (SIGMA ALDRICH CORPORATION): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
132 MERCK KGAA: OVERALL FINANCIALS, (2014-2016)
133 MERCK KGAA: NET REVENUE BY BUSINESS SEGMENTS, (2014-2016)
134 MERCK KGAA: NET REVENUE BY GEOGRAPHY, (2014)
135 MERCK KGAA: NET REVENUE BY GEOGRAPHY, (2015-2016)
136 MERCK KGAA: GLOBAL PRESENCE
137 MERCK KGAA: SWOT ANALYSIS
138 SYNTHEGO CORPORATION: OVERALL PRODUCT PORTFOLIO
139 SYNTHEGO CORPORATION: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
140 SYNTHEGO CORPORATION: SWOT ANALYSIS
141 SYSTEM BIOSCIENCES, LLC: OVERALL PRODUCT PORTFOLIO
142 SYSTEM BIOSCIENCES, LLC: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
143 SYSTEM BIOSCIENCES, LLC: SWOT ANALYSIS
144 TAKARA BIO INC. : OVERALL PRODUCT PORTFOLIO
145 TAKARA BIO INC. (TAKARA BIO USA INC.): PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
146 TAKAR BIO INC.: OVERALL FINANCIALS (2014-2017)
147 TAKARA BIO INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
148 TAKARA BIO INC.: NET REVENUE BY REGION (2014-2017)
149 TAKARA BIO INC.: GLOBAL PRESENCE
150 TAKARA BIO INC.: SWOT ANALYSIS
151 THERMO FISHER SCIENTIFIC INC.: OVERALL PRODUCT PORTFOLIO
152 THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
153 THERMO FISHER SCIENTIFIC INC.: OVERALL FINANCIALS (2014-2017)
154 THERMO FISHER SCIENTIFIC INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
155 THERMO FISHER SCIENTIFIC INC.: NET REVENUE BY REGION (2014-2016)
156 THERMO FISHER SCIENTIFIC INC.: GLOBAL PRESENCE
157 THERMO FISHER SCIENTIFIC INC.- SWOT ANALYSIS
158 TRANSOMIC TECHNOLOGIES INC.: OVERALL PRODUCT PORTFOLIO
159 TRANSOMIC TECHNOLOGIES INC.: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
160 TRANSOMIC TECHNOLOGIES INC.: SWOT ANALYSIS
161 TRANSPOSAGEN BIOPHARMACEUTICALS: OVERALL PRODUCT PORTFOLIO
162 TRANSPOSAGEN BIOPHARMACEUTICALS: PRODUCT PORTFOLIO FOR GLOBAL CRISPR TECHNOLOGY
163 TRANSPOSAGEN BIOPHARMACEUTICALS: SWOT ANALYSIS
164 GLOBAL CRISPR TECHNOLOGY MARKET SEGMENTATION
165 CONSIDERED FACTORS FOR DATA PREDICTION & MODELING
